Company intelligence / Profile preview
Taiho Oncology
Princeton, New Jersey, United Statestaihooncology.com ↗
- Ownership
- Private
- Employees
- ~414
- Development stage
- Other
01
Overview
Taiho Oncology has successfully commercialized two orally administered chemotherapy drugs in the US—LONSURF (trifluridine/tipiracil) for metastatic colorectal/gastric cancers and INQOVI (decitabine/cedazuridine) for myelodysplastic syndromes. The company’s pipeline includes additional small molecule candidates targeting both solid tumors and hematological malignancies at various stages of clinical development. LYTGOBI (futibatinib), an FGFR inhibitor for cholangiocarcinoma, received accelerated approval from the FDA in 2022.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Cullinan Oncology – joint development/commercialization of CLN‑081/TAS6417 EGFR inhibitor for NSCLC.Astex Pharmaceuticals – collaboration via parent Otsuka group for decitabine/cedazuridine program.
Beyond the preview
Go deeper on Taiho Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Taiho Oncology.